furosemide has been researched along with ergoline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Dujaili, EA; Besser, GM; Edwards, CR; Hanker, JP; Miall, PA; Thorner, MO | 1 |
| Azimi, S; Hamdani, S; Laborde, K; Sachs, C; Shahedi, M | 1 |
| Cevik, C; Feray, H; Izgi, C; Mansuroglu, D; Nugent, K; Saltan, Y | 1 |
1 trial(s) available for furosemide and ergoline
| Article | Year |
|---|---|
Inhibition of the plasma-aldosterone response to frusemide by bromocriptine.
Topics: Aldosterone; Bromocriptine; Dopamine; Ergolines; Furosemide; Humans; Injections, Intravenous; Mineralocorticoid Receptor Antagonists; Potassium; Renin; Sodium | 1975 |
2 other study(ies) available for furosemide and ergoline
| Article | Year |
|---|---|
Mechanisms of dopamine effects on Na-K-ATPase activity in Madin-Darby canine kidney (MDCK) epithelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3',5'-Cyclic-AMP Phosphodiesterases; Amiloride; Animals; Cell Line; Cyclic AMP-Dependent Protein Kinases; Dideoxyadenosine; Dogs; Domperidone; Dopamine; Dopamine D2 Receptor Antagonists; Epithelium; Ergolines; Furosemide; Isoquinolines; Kidney; Kidney Tubules, Collecting; Piperazines; Protein Kinase C; Quinpirole; Receptors, Dopamine D1; Sodium-Potassium-Exchanging ATPase | 1995 |
Severe tricuspid regurgitation in a patient receiving low-dose cabergoline for the treatment of acromegaly.
Topics: Acromegaly; Cabergoline; Diuretics; Echocardiography, Doppler, Color; Ergolines; Female; Furosemide; Heart Failure; Hormone Antagonists; Humans; Middle Aged; Severity of Illness Index; Treatment Outcome; Tricuspid Valve Insufficiency | 2010 |